Download Isoenzymes in Clinical Diagnosis

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Clinical neurochemistry wikipedia , lookup

Nicotinamide adenine dinucleotide wikipedia , lookup

Catalytic triad wikipedia , lookup

Photosynthetic reaction centre wikipedia , lookup

Lipid signaling wikipedia , lookup

Gel electrophoresis wikipedia , lookup

Myokine wikipedia , lookup

Size-exclusion chromatography wikipedia , lookup

Biosynthesis wikipedia , lookup

Deoxyribozyme wikipedia , lookup

Restriction enzyme wikipedia , lookup

Metalloprotein wikipedia , lookup

Enzyme inhibitor wikipedia , lookup

Western blot wikipedia , lookup

Glyceroneogenesis wikipedia , lookup

Citric acid cycle wikipedia , lookup

Metabolism wikipedia , lookup

NADH:ubiquinone oxidoreductase (H+-translocating) wikipedia , lookup

Proteolysis wikipedia , lookup

Biochemistry wikipedia , lookup

Amino acid synthesis wikipedia , lookup

QPNC-PAGE wikipedia , lookup

Oxidative phosphorylation wikipedia , lookup

Glycolysis wikipedia , lookup

Evolution of metal ions in biological systems wikipedia , lookup

Enzyme wikipedia , lookup

Lactate dehydrogenase wikipedia , lookup

Transcript
SPECIAL ARTICLE
Isoenzymes
in
Clinical Diagnosis
By THEODORE L. GOODFRIEND, M.D.,
AND
NATHAN 0. KAPLAN, PH.D.
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
The acid and alkaline phosphatases are not
usually designated as isoenzymes. This term
was first applied to enzymes that catalyzed
the same reaction but differed from one another in electrophoretic or chromatographic properties. For the purposes of this review, the
definition of isoenzymes will be broadened to
include all sets of enzymes that catalyze a
given reaction, regardless of the nature of
the differences among them. By this definition,
acid and alkaline phosphatases are isoenzymes,
and the recently described electrophoretic
forms within each of these groups are also
SERUM ENZYMES are useful tools for determining the location and severity of
many diseases. They are protein catalysts,
some of which enter the serum from damaged
tissues. Because they are catalysts, they are
more easily detected than many other substances. Amylase released from the diseased
pancreas,1 and phosphatase released from
several tissues2 have been studied for many
years and have established the usefulness of
serum enzyme tests.
Unfortunately, many of the best studied
and most easily detected enzymes occur in
more than one organ. Furthermore, some organs like liver and skeletal muscle contain
high concentrations of many enzymes and
frequently cause confusion in diagnosis
based on enzymes.
In one respect, however, the wide distribution of some enzymes is illusory: the enzyme
activity is widespread, but the specific protein
catalyst may vary from tissue to tissue. This
was recognized early in the case of phosphatases.3 Bone, prostate, and red cells are
rich in proteins catalyzing the hydrolysis of
phosphates, but the major phosphatases from
these tissues differ in pH optima and susceptibility to inhibition by a variety of chemicals.
Different enzyme molecules that catalyze the
same reaction are called "isoenzymes," 'isozymes," or "multiple molecular forms." Their
discovery has encouraged further searches for
organ-specific catalytic proteins.
isoenzymes.
Characteristics of Isoenzymes
Enzymes that catalyze the same reaction
may differ from one another in many ways,
ranging from small variations in secondary
structure to broad differences in amino acid
sequence and molecular weight. These criteria
are listed in table 1. At one extreme are enzymes with marked differences in structure,
but a common substrate. The esterases13 and
the peptidases'4 are probably in this class. At
the other extreme are molecules that are identical in all respects but their degree of denaturation. Separatory procedures are now so
sensitive that multiple forms of enzymes may
appear, which merely reflect artifacts of preparation or handling of the specimens. Relatively minor manipulations may introduce differences caused by the folding of enzyme
protein chains,4 the aggregation of chains into
polymers,5 the addition or removal of lipids,11
bound metals,15 or deamidation of carboxyl
amide groups.8 For clinical studies, the
isoenzymes with the greatest value are those
that differ in a fundamental way, which per-
From the Graduate Department of Biochemistry,
Brandeis University, Waltham, Massachusetts. Publication no. 393.
Supported in part by grants from the National Institutes of Health, U. S. Public Health Service, and
the National Science Foundation.
1010
Circ0lation, Volume XXXII, December 1965
ISOENZYMES IN CLINICAL DIAGNOSIS
1011
Table 1
Diferences in Isoenzymes
A. Physicochemical
1. Differences in secondary and tertiary structure, (folding of polypeptide chains), e.g.,
ref. 4
2. Different degrees of polymerization to dimers, tetramers, etc.5
B. Immunochemical
1. Different reactivity with specific antibodies.6
C. Chemical
1. Variations in degree of deamidation of carboxylamide groups or acetylation of amino
groups.7, 8
2. Variable combinations with carrier proteins, carbohydrates, coenzymes, prosthetic
groups, or lipid.9-11
3. Different degrees of activation or inactivation by hydrolytic cleavage of terminal
peptides, oxidation or reduction of coenzyme or sulfhydryl groups.
4. Varying degrees of amino acid differences.12
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
sists despite the influence of serum contaminants, storage, or analytic technics.
Detection of Isoenzymes
Two groups of phosphatase were originally
detected by their different pH optima and
called "acid" and "alkaline" phosphatase. Further "isoenzymes" of phosphatase were differentiated by susceptibility to inhibition by
tartrate and other chemicals.'6 Different pepsins were separated by differences in solubility.17 Since these early examples, methods of
differentiation have increased. The most widely used are technics of separation by electrophoresis or chromatography. The basic methods of isoenzyme detection and measurement
are listed in table 2.
Figure 1A is an example of lactic dehydrogenase isoenzymes (LDH), separated by electrophoresis and detected by a staining reaction
specific for this enzyme. Figure lB shows an
analogous pattern for creatine kinase. Once
separated, the isoenzymes may prove to have
different catalytic properties. For example, the
muscle and heart varieties of LDH behave
differently toward various concentrations of
their common substrate, as shown in figure
2. These differences, like different susceptibility to pH, inhibitors, and specific antibodies,
may be utilized for detecting and measuring
the various enzyme forms.
The isoenzymes that are currently most convenient for clinical diagnosis are those which
can be differentiated by simple assays using
Circulation, Volume XXXII, December 1965
small amounts of enzyme, and various conditions of heat treatment, pH, substrate concentration, or inhibitors. Such assays do not
require preliminary separation of the proteins by chromatography, etc. The heart and
muscle forms of LDH are examples of isoenzymes detectable by such chemical properties. In fact, the demonstration of experimental data like that shown in figure 2 is an
indication that such methods are applicable.
These curves indicate at a glance the conditions of assay that will differentiate the two
forms (shown by the vertical dotted lines),
one condition measures both forms equally
well, the second condition specifically inhibits
one of the two forms. Such an assay is precise and quantitative. If more than two isoenzymes are present, however, this type of
test may not give as complete a picture of the
spectrum of isoenzymes as electrophoresis or
chromatography. Finally it may be possible to adapt separatory procedures to a sort
of chemical assay. For example, isoenzymes
that adhere relatively firmly to materials used
in chromatography can be removed from assay mixtures by the "batch" addition of gel to
the specimen. In this way, the gel is used
instead of a chemical inhibitor.
Origin of Isoenzymes
The isoenzymes that differ in amino acid
composition, such as the isoenzymes of LDH,
probably represent the results of ancestral
mutation and gene duplication: a single gene
1012
GOODFRIEND. KAPLAN
Table 2
Alethods for Detection arnd Measunreinent of lshoeiZyjm es
A. 1b1wsicochemical
I. Separation by electtropborcsis.ls.
2. Separation
b)y chromattog:aph)l1yA
B. Ilalmmllwocl)emical
l. Combination vitl, 01. inhliil)ition 1by specific inti1bodies. 211
C. Chemical
1. Bate of reaiction und(ler vatriomus condlition.s of p112 temperiture,21 inhibitors,1" cociazyme
analogtue's, or substrate concentration.2
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
corresponding to a giveni enzyme gave rise to
two or more genes and two or more different
enzymes. Those isoenzymes that differ in
prosthetic groups, secondary structture, or
state of polymerization may have arisen by
other routes. In some cases, further evolution or environmental influences caused separate genes to become expressed to varying
degrees in different organs. This resuilted in the
organ-specific isoenizyme patterns under discussion. There are other instances, niotably
malic.' and TPN-linked isocitric dehydrogenases$2 in whiclh the isoenzymes are found in
many tissues l)ut are localized in different subcellular compartments, such as mitochondria
anid cytoplasm.
Genetic and evolutionary factors havce
given rise to differences in other well-studied
proteins uvhich share a common ftinction, such
as hemoglobins, haptoglobins, and gamma
globulins. Another exam-ple is the hormonepair oxytocin aind vasopressin, xhich share
common properties and probably arose from
a single ancestor like the vasotocin of loNver
forms. It has lonig been recognized that some
ssuch "iso" proteins vary from species to species, from race to race, or from person to person. The coexistence of mutltiple forms of enzymes or other proteins within the same
individual but localized in various organs is
the featuire that makes them useful in clinical
diagnosis.
The existence of two different genes for
fuinctionally related enzymes may give rise to
more than tu0o isoenizymes. This resuilts from
the fact that some enzy mes are composed of
A
S
LACTIC DEHYDROGENASE
LDH
ISOENZYMES
CREATINE KINASE
M4 M3}H
M2H2 MMH3 H
MHMH2MHH4
BRAI N
BRAIN
I
HEART
HEART
SKELETAL
MUSCLE
'Ro.
.- *
*
.
I
SKELETAL
MUSCLE
-
ORIGIN
I
t
ORIGIN
+
+
Figure 1
Isoeoizymes separcated by starcch-gel elceirophoresis. A shows tile lactic deehydrogenases fromt
young rat tissues, separated and stained accordling to the method of Fine et al.2 B shows the
creatine kinases from the same tissues separated mtild stairoecl occeording to the nmethods of EPppenberger et al.25
Circulaton, Volumie XXXII, Decelmber 1965
1013
ISOENZYMES IN CLINICAL DIAGNOSIS
diversity of LDH isoenzymes in some individuals, resulting in more than five forms of this
enzyme.29 These appear to be mutations affecting the gene for one of the two subunit
types.
100
Physiologic Significance of Isoenzymes
80
60
20
x
;.e
40
20
oL
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
33
10 4
3.3 lo0 3
PYRUVATE CONCENTRATION, M
10-3
Figure 2
Inhibition of two chicken isoenzymes of lactic dehydrogenase by pyruvate. The lines A and B indicate
two concentrations of pyruvate which could be used
to determine the relative amounts of the two isoenzymes (or their subunits) in a single sample,
(from Cahn et al.).23
subunits, analogous to the component chains
of hemoglobin or gamma globulin. A single
gene accounts for the structure of a single
subunit, but the intact enzyme can be composed of more than one subunit, and molecular
hybrids can occur. Thus, the five common isoenzymes of LDH are the products of only two
different genes, producing two kinds of subunits, which can combine in five different
ways to produce intact tetrameric enzyme
molecules.23 28 This is illustrated diagrammatically in figure 3. The gene for heart-type LDH
produces one kind of subunit, the H subunit,
and the gene for muscle-type LDH produces
M subunits. The complete enzyme contains
four subunits. In heart, the predominant tetramer is H4, in skeletal muscle it is M4, and,
in most other tissues, molecular hybrids of H
and M predominate. Thus, five isoenzymes
result from only two different genes. Enzymes that are dimers could have three isoenzymes as the result of two different genes
(fig. LB). The cell can thereby expand the
genetic complement into a wide spectrum of
isoenzyme patterns.
Genetic processes have given rise to further
Circulation, Volume XXXII, December 1965
The possible physiologic significance of isoenzymes is illustrated by lactic dehydrogenase. This enzyme catalyzes a reaction which,
in the direction pyruvate -> lactate, enables
glycolysis to provide energy in the absence
of oxygen. This reaction is important in tissues
such as skeletal and uterine muscle when energy from glycolysis is required during times of
reduced oxygenation. The isoenzymes of LDH
in these tissues are rich in muscle-type (M)
subunits, which have the property of functioning at high concentrations of pyruvate (fig.
2). Thus, these tissues can utilize the above
reaction when pyruvate cannot be oxidized.
On the other hand, the isoenzymes of LDH
found in heart are rich in H subunits and are
inhibited by high concentrations of pyruvate. This inhibition may retard the reaction
pyruvate -- lactate and promote the shunting
of pyruvate to oxidative pathways of the Krebs
cycle. In this way, the LDH isoenzymes in
heart muscle favor more complete utilization
of available energy in glucose. Furthermore,
the heart isoenzymes are better suited to
oxidize lactate; this may permit the heart to
extract lactate from the arterial blood and
use it as a metabolic fuel in addition to glu-
cose.23' 30
The other tissues of the body make intermediate demands on glycolysis and oxidation,
and their LDH is of intermediate type, con-
FM
SUBUNITS
TETRAMER
(ISOENZYME)
i 0i
i-m 9 i-m 0 i 0 0
W ( ((®®)
i®
i
(M4)
(M3H1) (M2H2) (M1H3)
im
i
®
®
(H4)
Figure 3
Diagrammatic representation of the formation of five
diferent isoenzymes from only two diferent subunits
(LDH), when the intact enzyme contains a total of
four subunits.
1014
GOODFRIEND, KAPLAN
tive and has not proved adequate by itself
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
taining molecular hybrids of M and H subunits, and reacting in an intermediate way
with pyruvate. The fine adjustment of metabolism, which can be aided by various proportions of H and M subunits in LDH, is illustrated in table 3. The two zones of the kidney
vary in oxygen tension because of the countercurrent circulatory system: the medulla is anaerobic relative to the cortex.31 They also vary
in their dependence on anaerobic glycolysis
for energy: the medulla utilizes anaerobic
pathways more extensively than does the cortex.32 Finally, there is a parallel variation in the
proportion of subunits in the LDH from these
zones: the anaerobic medulla contains muscle
type, and the oxidative cortex contains mostly
heart-type enzyme.30 This difference in metabolic and isoenzyme pattern from cortex to
medulla may prove useful in the diagnosis and
localization of renal disease by tests on blood
or urine.
In addition to the differences observed in
tissues of adult organisms, the proportions of
the two kinds of LDH subunits can be made
to vary further by changes in environment.
In the uterus. estradiol induces preferential
synthesis of M subunits ("preparing" the organ
for its anaerobic, muscle-like adult function
In tissue culture,
during parturition) .
changes in oxygen tension alter the synthesis
of the subunits to different degrees.34 As might
be predicted, the synthesis of M subunits is
favored by anaerobic conditions. These observations reenforce the concept that isoenzyme differences serve a physiologic pur-
for the diagnosis of cancer.35
Differences in isoenzyme properties which
might correlate with physiology have also been
described for malic dehydrogenase, glutamic
dehydrogenase, and phosphofructokinase. The
malic dehydrogenase isoenzymes differ in their
resistance to high concentrations of malate,
depending on their subcellular site of origin,
that from mitochondria resisting high malate
better than that from the cytoplasm.36 3" This
is consistent with the fact that malate is oxidized primarily inside mitochondria. Glutamic
dehydrogenase isoenzymes vary in catalytic
activity. The less active form, which can be
produced in vitro by high concentrations of
ATP, probably predominates when oxidation
of glutamate for energy is unnecessary and
ATP levels are high. Oxidation of glutamate
by the more active form of enzyme is favored
when
energy
is needed and ATP is low.38
Finally,
phosphofructokinase from heart
is more resistant to ATP inhibition than the
enzyme from other tissues.30 This correlates
with the high levels of ATP in heart compared
to other tissues.
The isoenzymes of glutamic dehydrogenase,
which differ in molecular weight as well as
catalytic properties, are composed of varying
numbers of subunits. Furthermore, the isoenzymes are interconvertible, and the conversion appears to be under metabolic and endocrine control.40 This may represent the use of
isoenzymes by the cell for a constant fine adjustment of enzyme activity. Although the
majority of isoenzymes are not so readily interconvertible, many more examples of interconvertible forms will probably come to light.
If such interconversions were to occur among
pose.30
It has been shown that the proportion of M
subunits in tumors is higher than in normal
tissues. However, the difference is only rela-
Table 3
Comparison of Oxygen Supply, Oxygen Utilization, and Glycolysis with Composition
of LDH Isoenzymes in Zones of the Kidney from Various Species
Medulla
Cortex
(human) (mm. Hg),
(31)
Oxygen tension;
Glycolysis;
(dogs), (Al.
C02 released
from medium/
mg. dry wt.
hr.), (32)
20-60
90
5.1
1.4
ut(lg
zation; (dogs),
Oxygen
(-Qo,), (32)
M-subunits in
LDH: (rat), per
cent, (30)
2.3
14.1
56
2
Circulafion, Volume
XXXII, December 1965
ISOENZYMES IN CLINICAL DIAGNOSIS
1015
multiple forms, all of which were fairly stable,
the resulting isoenzyme patterns would provide accurate reflections of the momentary
physiologic (or pathologic) states in tissues.
ables that are subject to analysis. In the absence of absolutely organ-specific enzymes or
isoenzymes, the greater number of proteins
improves the diagnostic potential of this type
of test.
It may become possible to incorporate tests
for many relatively specific "iso-" proteins into
one over-all test by the use of antisera. Since
a classical means of identifying isoenzymes is
immunologic, it should be possible to develop
a series of organ-specific or tissue-specific antisera. If it were possible to detect the very
small antigen-antibody reactions that would
result when pathologic samples were exposed
to organ-specific antisera, this kind of test
would serve as a simultaneous screening procedure for a sum of many immunologically
distinct isoenzymes and other antigens.
Difficulties in Interpreting Isoenzyme
Patterns
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
All cells share the same genes and are theoretically capable of producing the same proteins, including isoenzymes. Although there
are obvious marked differences in the localization of some proteins from tissue to tissue,
the differences in enzymes and isoenzymes are
likely to be relative rather than absolute. This
is the feature that has long obscured interpretation of standard serum enzyme tests. Use
of isoenzymes decreases this confusion somewhat, because it increases the number of vari-
Table 4
Selected List of Mammalian Enzymes with MIultiple Molecular Forms (Isoenzymes)
Enzyme
Usual number of isoenzymes
Lactic dehydrogenase
Creatine kinase
5
Phosphofructokinase
Aldolase
Phosphorylase
Aminopeptidase
Fructose 1, 6 diphosphatase
Ribonuclease
Hexokinase
Phosphatase
>2
Esterase
Deoxyribonuclease
Amylase
Glutamic dehydrogenase
Pepsin
Isocitric dehydrogenase
(TPN)
Malic dehydrogenase
Glutamic-oxalacetic
3
2
3
Isoenzymes
differ in
tissue or
organ localization
+
+
+
I soenzymes
differ in
catalytic
properties
or stability
+
+
Subunits
proved
cated
or indi-
+
+
+
+
>3
2
2
4
>3
>3
2
>2
6
4
+
+
+
+
+
+
(+)
+
Reference
no.
51,
54,
39
56
20,
14,
52, 53*
55*
57
58,* 59*
60
0
10, 61, 62*
63, 64, 65
2, 6, 16, 66,* 67*
13
68, 69*
70
38, 71
17, 72*
27
26, 37
2
>2
2
+
19, 73
2
+
74
>3
2
2
2
+
76
77
78
transaminase
Histidine-pyruvic transaminase
Glucose-6-phosphate
dehydrogenase
Galactokinase
Carbonic anhydrase
Tyrosinase
*Reports directly relat :ed to clinical medicine.
Circulation, Volume XXXII, December 1965
19, 75*
1016
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
The preceding section described changes in
isoenzyme patterns that may be caused by
many physiologic or environmental conditions
in vivo. Recent evidence also indicates that
changes may occur depending on the time of
day, in accordance with a "biological clock"
mechanism.41 Furthermore, because they are
different molecules, isoenzymes are handled
differently by the body after they are released
into the circulation. The various transaminases
are cleared from the circulation at different
rates,42 and the clearance of lactic dehydrogenase in mice is affected by a virus.43 As
mentioned in the first section of this review,
many changes in isoenzyme pattern can be
induced by heat, acid, and solvents. Finally,
the isoenzymes that result from various combinations of subunits often can be dissociated
and reassociated in vitro.44 45 Because of this
recombination, a sample that has been frozen
and thawed may exhibit a different isoenzyme
pattern from the fresh sample.
Thus, physiologic, pathologic, and physicochemical factors bear upon the isoenzyme pattern during its passage through the cell, circulation, and laboratory. At the very least,
conditions of collection, storage, separation,
and assay must be standardized before isoenzyme comparisons are valid.
Summary
The recent literature attests to the increasing number of enzymes for which isoenzymes
or subunit structure or both are known. Several symposia and reviews have been published within the past few years.4>50 Some
enzyme activities for which isoenzymes have
been described are listed in table 4. Only
those found in mammals are included. They
are ranked in rough order of apparent usefulness in clinical diagnosis, with the enzymes
displaying tissue localization and catalytic differences listed first. Also, the number of molecular forms and the presence or absence of
known subunit structure is indicated.
Clinical studies have been made using several of the isoenzymes listed in table 4, and
references denoting these studies are marked
with an asterisk. Data presented in the table
GOODFRIEND, KAPLAN
indicate that valuable clinical information
might derive from study of other isoenzymes,
notably phosphofructokinase, for which tissue
differences and adaptable catalytic differences
exist. The guidelines set forth in this review
can be used for investigating still other isoenzymes, such as those studied in lower
forms.79-85 In brief, the study of isoenzymes,
like the study of enzymes and other organspecific chemicals, presents an opportunity for
great specificity and accuracy in localizing
and following disease processes.
Acknowledgment
The authors are indebted to Dr. H. Eppenberger
for figure 1, and to Dr. L. Corman and Mr. J. Everse
for assistance in translation.
References
1. WOHLGEMUTH, J.: Vber eine neue Methode zur
quantiativen Bestimmung des diastaphischen
Fermens. Bioch. Ztschr. 9: 1, 1908.
2. KAY, H. D.: Plasma phosphatase in osteitis deformans and other diseases of bone. Brit. J.
Exper. Path. 10: 253, 1929.
3. RocnzE, J.: Blood phosphatases. Biochem. J. 25:
1724, 1931.
4. MARGOLIASH, E., AND LUSTGARTEN, J.: The
chromatographic forms of cytochrome c. Ann.
New York Acad. Sc. 94: 731, 1961.
5. TRAYSER, K. A., AND COLOWICK, S. P.: Properties
of crystalline hexokinase from yeast. Arch.
Biochem. & Biophys. 94: 177, 1961.
6. SCHLAMOWrrZ, M.: Specificity of dog intestinal
phosphatase antiserum. J. Biol. Chem. 206:
369, 1954.
7. TANFORD, C., AND HAUENSTEIN, J. P.: Identification of the chemical differences between chromatographic components of ribonuclease. Biochim. et Biophys. acta 19: 535, 1956.
8. CARPENTER, F. H., AND HAYS, S. L.: Electrophoresis on cellulose acetate of insulin and
insulin derivatives. Biochem. 2: 1272, 1963.
9. MITIDIER, E., RIBIERO, L. P., AFFONSO, 0. R.,
AND VILLELA, G. G.: Localization of xanthine
dehydrogenase in rat serum by paper electrophoresis. Biochim. et biophys. acta 17: 587,
1955.
10. PLUMMER, T. H., AND Hms, C. H. W.: On the
structure of pancreatic ribonuclease B. J. Biol.
Chem. 239: 2530, 1964.
1 1. SOPHIANOPOULOS, A. J., AND VESTLING, C. S.:
Circulation, Volume XXXII, December 1965
ISOENZYMES IN CLINICAL DIAGNOSIS
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
Nature of the two forms of malic dehydrogenase from rat liver. Biochim. et biophys.
acta 45: 400, 1960.
12. WIELAND, T., AND PFLEIDERER, G.: Multiple Formen von Enzymen. In Advances in Enzymology, F. Nord, Ed., New York, Interscience
Publishers, 1963.
13. AUGUSTINSSON, K.: Multiple forms of esterase in
vertebrate blood plasma. Ann. New York
Acad. Sc. 94: 844, 1961.
14. NACHLAS, M. M., GOLDSTEIN, T. P., AND SELIGMAN, A. M.: An evaluation of aminopeptidase
specificity with seven chromogenic substrates.
Arch. Biochem. & Biophys. 97: 223, 1962.
15. WATTS, D. C., AND DONNIGER, C.: Starch gel
electrophoresis as a criterion for the purity of
crystalline yeast alcohol dehydrogenase. Analyt.
Biochem. 3: 489, 1962.
16. BODANSKY, O.: Are the phosphatases of bone,
kidney, intestine, and serum identical? J. Biol.
Chem. 118: 341, 1937.
17. DESREUX, V., AND HEIuIOTT, R. M.: Existence
of several active components in crude pepsin
preparations. Nature 144: 287, 1939.
18. SMrrHEs, O.: Zone electrophoresis in starch gels.
Biochem. J. 61: 629, 1955.
19. MOORE, B. W., AND LEE, R. H.: Chromatography
of rat liver soluble proteins and localization of
enzyme activities. J. Biol. Chem. 235: 1359,
1960.
20. HENION, W. F., AND SUTHERLAND, E. W.: Immunological differences of phosphorylases. J.
Biol. Chem. 224: 477,1957.
21. FONDY, T. P., PESCE, A., FREEDBERG, I., STOLZENBACH, F., AND KAPLAN, N. O.: The comparative enzymology of lactic dehydrogenases. Biochem. 3: 522, 1964.
22. KAPLAN, N. O., CIOTTI, M. M., HAMOLSKY, M.,
AND BIEBER, R.: Molecular heterogeneity and
evolution of enzymes. Science 131: 392, 1960.
23. CAHN, R. D., KAPLAN, N. O., LEvINE, L., AND
ZWILLING, E.: Nature and development of
lactic dehydrogenases. Science 136: 962, 1962.
24. FINE, I. H., KAPLAN, N. O., AND KUFTINEc, D.:
Developmental changes of mammalian lactic
dehydrogenases. Biochem. 2: 117, 1963.
25. EPPENBERGER, H. M., EPPENBERGER, M., RIcHTERIcH, R., AND AEBI, H.: The ontogeny of
creatine kinase isozymes. Developmental Biol.
10: 1, 1964.
26. DELLBRUCK, A. H., SCMMASSEK, H., BARTSCH,
K., AND BUCHER, T.: Enzym-Verteilungsmuster
in einigen Organen und in experimentellen
Tumoren der Ratte und der Maus. Biochem.
Ztschr. 331: 297, 1959.
27. LOWENSTEIN, J. M., AND SMITH, S. R.: Intraand extra-mitochondrial isocitrate dehydrogenases. Biochem. et biophys. acta 56: 385, 1962.
28. APPELLA, E., AND MARKERT, C. L.: Dissociation
Circulation, Volume XXXII, December 1965
1017
of lactate dehydrogenase into subunits with
guanidine hydrochloride. Biochem. Biophys.
Res. Commun. 6: 171, 1961.
29. FRrrz, P. J., AND JACOBSEN, K. B.: Lactic dehydrogenases: Subfractionation of isozymes. Science 140: 64, 1963.
30. DAWSON, D. M., GOODFRIEND, T. L., AND KAPLAN, N. O.: Lactic dehydrogenases: Functions
of the two types. Science 143: 929, 1964.
31. LEONHARDT, K. O., AND LANDES, R. R.: Oxygen
tension of the urine and renal structures. New
England J. Med. 269: 115, 1963.
32. KEAN, E. L., ADAMS, R. H., WINTERS, R. W.,
AND DAVIES, R. E.: Energy metabolism of the
renal medulla. Biochim. et biophys. acta 54:
474, 1961.
33. GOODFRIEND, T. L., AND KAPLAN, N. O.: Effects
of hormone administration on lactic dehydrogenase. J. Biol. Chem. 239: 130, 1964.
34. GOODFRIEND, T. L., SOKOL, D., AND KAPLAN, N.
O.: Control of synthesis of lactic acid dehydrogenases. J. Mol. Biol. In press.
35. GOLDMAN, R. D., AND KAPLAN, N. O.: Lactic
dehydrogenase in human neoplastic tissue.
Cancer Res. 24: 387, 1964.
36. THORNE, C. J. R.: Characterization of two malic
dehydrogenases from rat liver. Biochim. et
biophys. acta 42: 175, 1960.
37. THORNE, C. J. R., GROSSMAN, L. I., AND KAPLAN, N. O.: Starch gel electrophoresis of
malate dehydrogenase. Biochim. et biophys.
acta 73: 193, 1963.
38. FRIEDEN, C.: Glutamic dehydrogenase. J. Biol.
Chem. 234: 815, 1959.
39. LOWRY, O., AND PASSONNEAU, J.: A comparison of
the kinetic properties of phosphofructokinase
from bacteria, plant, and animal sources. Arch.
exper. Path. u. Pharmacol. 248: 185, 1964.
40. YIELDING, K. L., AND TOMKINS, G. M.: Structural alterations in crystalline glutamic dehydrogenase induced by steroid hormones. Proc.
Nat. Acad. Sc. (U.S.) 46: 1483, 1960.
41. DOE, R. P., AND MELLINGER, G. T.: Circadian
variation in serum alkaline phosphatase in
prostatic cancer. Metabolism 13: 445, 1964.
42. FLEIScHER, G. A., AND WAKIM, K. G.: The fate
of enzymes in body fluids. J. Lab. & Clin.
Med. 61: 76, 1963.
43. NOTKINS, A. L., AND SCHEELE, C.: Impaired
clearance of enzymes in mice infected with
the lactic dehydrogenase agent. J. Nat. Cancer
Inst. 33: 741, 1964.
44. MARKERT, C. L.: Lactate dehydrogenase isozymes: Dissociation and recombination of subunits. Science 140: 1329, 1963.
45. CHILSON, 0. P., COSTELLO, L. A., AND KAPLAN,
N. O.: Effects of freezing on enzymes. Fed.
Proc. 24: S-55, 1965.
46. WROBLEWSKI, F., ED.: Multiple molecular forms
1018
GOODFRIEND, KAPLAN
of enzymes. Ann. New York Acad. Sc. 94:
655, 1961.
47. WIELAND, T., AND PFLEIDERER, G.: Multiple
Formen von Enzymen. Adv. Enzymol. 25:
329, 1963.
48. KAPLAN, N. 0., ED.: Symposium on multiple
forms of enzymes and control mechanisms.
Bact. Rev. 27: 155, 1963.
63. VINUELA, E., SALAS, M.,
49. BROOKHAVEN, NATIONAL LABORATORY SYMPOSIA
IN BIOLOGY, No. 17: Subunit Structure of Proteins. Upton, New York, 1964.
50. LAWRENCE, S. H.: The Zymogram in Clinical
Medicine. Springfield, Illinois, Charles C
65.
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
Thomas, Publisher, 1964.
51. NiELANDs, J. B.: Studies on lactic dehydrogenase
of heart. J. Biol. Chem. 199: 373, 1952.
52. VESELL, E. S., AND BEARN, A. G.: Localization
of lactic acid dehydrogenase activity in serum
fractions. Proc. Soc. Exper. Biol. & Med. 94:
96, 1957.
53. COHEN, L., DJORDJEVICH, J., SND ORMISTE, V.:
Serum lactic dehydrogenase isozyme patterns
in cardiovascular and other diseases, with
particular reference to acute myocardial infarction. J. Lab. & Clin. Med. 64: 355, 1964.
54. BURGER, A., EPPENBERGER, M., WIESMAN, U.,
AND RICHTERICH, R.: Isoenzymen der CreatinKinase. Helvet. physiol. et pharmacol. acta
21: C-6, 1963.
55. HESS, J. W., MACDONALD, R. P., FREDERICK,
R. J., JONEs, R. N., NEELY, J., AND GROSs, D.:
Serum creatine phosphokinase activity in disorders of heart and skeletal muscle. Ann. Int.
Med. 61: 1015, 1964.
56. RUTTER, W. J., RICHARDS, 0. C., AND WOODFIN,
B. M.: Comparative studies of liver and muscle aldolase. J. Biol. Chem. 236: 3193, 1961.
57. BUEDING, E., KENT, N.,
AND
64.
66.
67.
68.
69.
70.
71.
72.
FISHER, J.: Tissue
specificity of glycogen phosphorylase b of intestinal smooth muscle. J. Biol. Chem. 239:
2099, 1964.
58. KOWLESSAR, 0. D., HAEFFNER, L. J., AND SLEI
SENGER, M. H.: Localization of leucine aminopeptidase in serum and body fluids by starch
gel electrophoresis. J. Clin. Invest. 39: 671,
1960.
59. SMITH, E. E., AND RUTENBERG, A. M.: Electrophoretic behavior of an aminopeptidase of
human tissues and serum. Nature 197: 800,
1963.
60. SALAS, M., VINUELA, E., SALAS, J., AND SOLS, A.:
Muscle fructose-i, 6 diphosphatase. Biochem.
Biophys. Res. Comm. 17: 150, 1964.
61. MARTIN, A. J. P., AND PORTER, R. R.: The
chromatographic fractionation of ribonuclease.
Biochem. J. 49: 215, 1951.
62. DELANEY, R.: Chemical, physical, and enzymatic
properties of several human ribonucleases. Biochem. 2: 438, 1963.
73.
74.
AND SOLS, A.: Glucokinase and hexokinase in liver in relation to
glycogen synthesis. J. Biol. Chem. 238:
PC1175, 1963.
GONZALEZ, C., URETA, T., SANCHEZ, R., AN-)
NIEMEYER, H.: Multiple forms of ATP: hexose
6-phosphotransferase from rat liver. Biochem.
Biophys. Res. Comm. 16: 347, 1964.
KATZEN, H. M., SODERMAN, D. P., AND NITOWSKY, H. M.: Kinetic and electrophoretic evidence for multiple forms of glucose-ATP
phosphotransferase activity from human cell
cultures and rat liver. Biochem. Biophys. Res.
Comm. 19: 377, 1965.
MoosRE, B. W., AND ANGELETTI, P.: Chromatographic heterogeneity of some enzymes in
normal tissues and tumors. Ann. New York
Acad. Sc. 94: 659, 1961.
SCHLAMOWITZ, M., AND BODANSKY, O.: Tissue
sources of human serum alkaline phosphatase as determined by immunochemical procedures. J. Biol. Chem. 234: 1433, 1959.
ALLFREY, V., AND MIRSKY, A. E.: Some aspects
of the desoxyribonuclease activities of animal tissues. J. Gen. Physiol. 36: 227, 1952.
GAvosTo, F., BUFFA, F., AND MARAINI, G.: Serum deoxyribonucleases I and II in pathologic conditions other than pancreatic diseases. Clin. chimica acta 4: 192, 1959.
MCGEACHIN, R. L., AND REYNOLDS, J. M.: Serological differentiation of amylase isoenzymes.
Ann. New York Acad. Sc. 94: 996, 1961.
VAN DER HELM, H. J.: L-Glutamate dehydrogenase isoenzymes. Nature 194: 773, 1962.
SEIJFFERS, M. J., SEGAL, H. L., AND MILLER, L.
L.: Chromatographic separation of pepsins
from human gastric juice. Am. J. Physiol.
207: 8, 1964.
FLEISHER, G. A., POTTER, C. S., AND WAKIM, K.
G.: Separation of two glutamic-oxalacetic
transaminases by paper electrophoresis. Proc.
Soc. Exper. Biol. & Med. 103: 229, 1960.
SPOLTER, H., AND BALDRiDGE, R. C.: Multiple
forms of histidine-pyruvate transaminase in
rat liver. Biochim. et biophys. acta 90: 287,
1964.
75. BOYER, S. H., PORTER, I. H., AND WEILBACHER,
R. G.: Electrophoretic heterogeneity of glu-
cose-6-phosphate dehydrogenase and its relationship to enzyme deficiency in man. Proc.
Nat. Acad. Sc. (U. S.) 48: 1868, 1962.
76. CUATRECASAS, P., AND SEGAL, S.: Galactokinase
and the control of galactose metabolism. Clin.
Res. 13: 321, 1965.
77. NYMAN, P. O.: Purification and properties of
carbonic anhydrase from human erythrocytes.
Biochim. et biophys. acta 52: 1, 1961.
78. SHIMAO, K.: Partial purification and kinetic
Circulation, Volume XXXII, December 1965
ISOENZYMES IN CLINICAL DIAGNOSIS
1019
studies of mammalian tyrosinase. Biochim. et
biophys. acta 62: 205, 1962.
79. Tsuyuii, H., AND WOLD, F.: Enolase: Multiple
molecular forms in fish muscle. Science 146:
535, 1964.
80. JOLLIES, P., AND ZIULI, S.: Purification et etude
82. VAN Eys, J., JUDD, J., FoRD, J., AND WOMACK,
comparee de nouveaux lysozymes. Biochim.
et biophys. acta 39: 212, 1960.
81. HAYMAN, S., AND ALBERTY, R. A.: The isolation
and kinetics of two forms of fumarase from
torula yeast. Ann. New York Acad. Sc. 94:
812, 1961.
W. B.: On the chemistry of rabbit muscle aglycerophosphate dehydrogenase. Biochem. 3:
755, 1964.
83. CHYTIL, F.: Mammalian j3-galactosidase. Biochem. Biophys. Res. Comm. 19: 630, 1965.
84. WILLIAMS, R. A. D.: Location of glyceraldehyde3-phosphate dehydrogenase in starch-gels. Nature 203: 1070, 1964.
85. PAUL, J., AND FOTTRELL, P. F.: Molecular variations in similar enzymes from different species.
Ann. New York Acad. Sc. 94: 668, 1961.
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
NEW MANUSCRIPTS
Authors are requested to send all new manuscripts for CIRCULATION to:
Howard B. Burchell, M.D.
CIRCULATION
Plummer Building
200 First Street SW
Rochester, Minnesota 55902
Please note that correspondence concerning manuscripts sent to
CIRCULATION before July 1, 1965 should be addressed to Herrman L.
Blumgart, M.D., 330 Brookline Avenue, Boston, Massachusetts 02215.
Circulation, Volume XXXII, December 1965
Isoenzymes in Clinical Diagnosis
THEODORE L. GOODFRIEND and NATHAN O. KAPLAN
Downloaded from http://circ.ahajournals.org/ by guest on June 14, 2017
Circulation. 1965;32:1010-1019
doi: 10.1161/01.CIR.32.6.1010
Circulation is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231
Copyright © 1965 American Heart Association, Inc. All rights reserved.
Print ISSN: 0009-7322. Online ISSN: 1524-4539
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://circ.ahajournals.org/content/32/6/1010
Permissions: Requests for permissions to reproduce figures, tables, or portions of articles
originally published in Circulation can be obtained via RightsLink, a service of the Copyright
Clearance Center, not the Editorial Office. Once the online version of the published article for
which permission is being requested is located, click Request Permissions in the middle column of
the Web page under Services. Further information about this process is available in the Permissions
and Rights Question and Answer document.
Reprints: Information about reprints can be found online at:
http://www.lww.com/reprints
Subscriptions: Information about subscribing to Circulation is online at:
http://circ.ahajournals.org//subscriptions/